Trials / Completed
CompletedNCT00144651
Study of MRA in Patients With Rheumatoid Arthritis (RA)
An Open-label, Extension, Phase II Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With RA Who Were Participated in Study MRA009JP
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 135 (actual)
- Sponsor
- Chugai Pharmaceutical · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, extension, Phase II study to evaluate the long-term safety and efficacy of MRA in Patients with RA who were participated in Study MRA009JP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MRA(Tocilizumab) | 8mg/kg/4 weeks for 1 year |
Timeline
- Start date
- 2001-08-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2005-09-05
- Last updated
- 2013-08-09
Source: ClinicalTrials.gov record NCT00144651. Inclusion in this directory is not an endorsement.